View All Upcoming Sponsored Webinars
April 14, 2016
Pharmacogenetics is playing an increasingly important role in personalized medicine, yet it faces a number of challenges when implemented in a clinical setting. In this webinar, Dr. Stuart Scott from the Icahn School of Medicine at Mount Sinai will discuss the factors influencing successful translation of the science into the clinic and how cost-effective solutions can expand the laboratory’s capabilities.
Who Should Attend:
Dr. Stuart Scott, PhD
Assistant Professor Genetics and Genomic Sciences, Department of Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
Dr. Stuart Scott got his PhD from the University of Saskatchewan, Canada, under the mentorship of hematopathologist Dr. John F. DeCoteau. His interest in medical genetics and molecular pathology prompted postdoctoral American Board of Medical Genetics and Genomics (ABMGG) training in Clinical Molecular Genetics and Clinical Cytogenetics at the Mount Sinai Genetic Testing Laboratory (MGTL) and Board certification in both specialties. Dr. Scott is an Associate Director of the MGTL, which is a CLIA and New York State (NYS) approved and CAP accredited clinical genetics laboratory with Biochemical Genetics, Cytogenetics and Cytogenomics, and Molecular Genetics subdivisions. In the MGTL, he is involved in high-complexity clinical molecular testing, including array-based comparative genomic hybridization, exome sequencing, and pharmacogenetic testing. Dr. Scott is a Co-Investigator of the Institute for Personalized Medicine’s (IPM)-PGx and eMERGE-PGx programs by providing expertise in clinical genetics and implementing clinical pharmacogenetic testing at Mount Sinai. The clinical pharmacogenetics implementation projects at IPM are pre-emptively genotyping a panel of pharmacogenetic variants through the MGTL among prospectively enrolled patients at selected Mount Sinai clinics as well as patients enrolled in the BioMe biobank. This program seeks to develop process best practices for successful translation of pharmacogenomics and personalized medicine discoveries into clinical practice.
Divya Neelam, MSc
Manager, Applications Marketing
Agena Bioscience, Inc.
Divya Neelam, Manager of Applications Marketing at Agena Bioscience, oversees the commercial programs to support Agena’s scientific marketing initiatives. Over the past 9 years, Divya has worked closely with the users of the MassARRAY platform through her role as a bioinformatics and network support engineer and as an applications and technology scientist. She received her Master’s in Bioinformatics from Indiana University, Bloomington, Indiana.
250 First Avenue, Suite 300
Needham, MA 02494
Biological Therapeutic Products
Biomarkers & Diagnostics
Bioprocess & Manufacturing
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
IT & Informatics
Technology & Tools For Life Science
Cambridge Healthtech Institute
Cambridge Innovation Institute